|
Volumn 26, Issue 4, 2011, Pages 44-45
|
Interim guidance for PrEP in MSM. CDC: Do not expand to other risk groups yet.
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DEOXYCYTIDINE;
DRUG DERIVATIVE;
EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;
ORGANOPHOSPHORUS COMPOUND;
ARTICLE;
DRUG COMBINATION;
HOMOSEXUALITY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MALE;
RISK FACTOR;
DEOXYCYTIDINE;
DRUG COMBINATIONS;
HIV INFECTIONS;
HOMOSEXUALITY, MALE;
HUMANS;
MALE;
ORGANOPHOSPHORUS COMPOUNDS;
RISK FACTORS;
|
EID: 79957810055
PISSN: 08870292
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (0)
|